These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12042051)

  • 1. Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
    Joshi SS; Miller K; Jackson JD; Warkentin P; Kessinger A
    Cytotherapy; 2000; 2(1):15-24. PubMed ID: 12042051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
    Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
    J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.
    Burns LJ; Weisdorf DJ; DeFor TE; Repka TL; Ogle KM; Hummer C; Miller JS
    Exp Hematol; 2000 Jan; 28(1):96-103. PubMed ID: 10658681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections.
    Miller JS; Prosper F; McCullar V
    Blood; 1997 Oct; 90(8):3098-105. PubMed ID: 9376591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.
    Gazitt Y; Shaughnessy P; Devore P
    J Hematother Stem Cell Res; 2001 Feb; 10(1):177-86. PubMed ID: 11276371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics.
    Joshi SS; Lynch JC; Pavletic SZ; Tarantolo SR; Pirruccello SJ; Kessinger A; Bishop MR
    Blood; 2001 Sep; 98(6):1963-70. PubMed ID: 11535536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor.
    Takenaka K; Mizuno SI; Harada M; Nagafuji K; Miyamoto T; Iwasaki H; Fujisaki T; Kubota A; Ohno Y; Arima F; Shigematsu H; Gondo H; Okamura T; Okamura S; Inaba S; Niho Y
    Br J Haematol; 1996 Mar; 92(4):788-94. PubMed ID: 8616068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of mobilization with medium dose of rhG-CSF on the immunocyte component of peripheral blood in donors].
    Huang WR; Da WM; Deng XL; Gao CJ; Han XP; Wu XX; Li HH; Zhu HY; Jin HJ; Jing Y; Wang SH; Bo J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):852-6. PubMed ID: 16277857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in beta-thalassemia patients: kinetics of mobilization and composition of apheresis product.
    Li K; Wong A; Li CK; Shing MM; Chik KW; Tsang KS; Lai H; Leung TF; Yuen PM
    Exp Hematol; 1999 Mar; 27(3):526-32. PubMed ID: 10089916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
    Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
    Ozerol I; Ageitos A; Heimann DG; Talmadge JE
    Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections.
    Verbik DJ; Jackson JD; Pirruccello SJ; Patil KD; Kessinger A; Joshi SS
    Blood; 1995 Apr; 85(7):1964-70. PubMed ID: 7703499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells.
    Kang J; Yun JY; Hur J; Kang JA; Choi JI; Ko SB; Lee J; Kim JY; Hwang IC; Park YB; Kim HS
    Cardiovasc Res; 2014 Oct; 104(1):171-82. PubMed ID: 25082847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization.
    Olivieri A; Offidani M; Cantori I; Ciniero L; Ombrosi L; Masia MC; Brunori M; Montroni M; Leoni P
    Bone Marrow Transplant; 1995 Dec; 16(6):765-70. PubMed ID: 8750267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF.
    Perillo A; Pierelli L; Scambia G; Serafini R; Paladini U; Salerno MG; Bonanno G; Fattorossi A; Leone G; Mancuso S; Menichella G
    Transfusion; 2001 May; 41(5):674-80. PubMed ID: 11346705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.